These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29790240)

  • 21. Hormonal influence on HIV-1 transmission in the female genital tract: New insights from systems biology.
    Dupont HA; Lam J; Woods MW; Zahoor MA; Kaushic C
    Am J Reprod Immunol; 2018 Aug; 80(2):e13019. PubMed ID: 30014538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genital inflammation, immune activation and risk of sexual HIV acquisition.
    Passmore JA; Jaspan HB; Masson L
    Curr Opin HIV AIDS; 2016 Mar; 11(2):156-62. PubMed ID: 26628324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cataloguing of Potential HIV Susceptibility Factors during the Menstrual Cycle of Pig-Tailed Macaques by Using a Systems Biology Approach.
    Vishwanathan SA; Burgener A; Bosinger SE; Tharp GK; Guenthner PC; Patel NB; Birse K; Hanson DL; Westmacott GR; Henning TR; Radzio J; Garcia-Lerma JG; Ball TB; McNicholl JM; Kersh EN
    J Virol; 2015 Sep; 89(18):9167-77. PubMed ID: 26109722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.
    Rebbapragada A; Wachihi C; Pettengell C; Sunderji S; Huibner S; Jaoko W; Ball B; Fowke K; Mazzulli T; Plummer FA; Kaul R
    AIDS; 2007 Mar; 21(5):589-98. PubMed ID: 17314521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaginal microbiota and its role in HIV transmission and infection.
    Petrova MI; van den Broek M; Balzarini J; Vanderleyden J; Lebeer S
    FEMS Microbiol Rev; 2013 Sep; 37(5):762-92. PubMed ID: 23789590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current concepts of HIV transmission.
    Morrow G; Vachot L; Vagenas P; Robbiani M
    Curr HIV/AIDS Rep; 2007 Feb; 4(1):29-35. PubMed ID: 17338858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The barrier to HIV transmission provided by genital tract Lactobacillus colonization.
    Mirmonsef P; Spear GT
    Am J Reprod Immunol; 2014 Jun; 71(6):531-6. PubMed ID: 24661438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
    Chappell CA; Isaacs CE; Xu W; Meyn LA; Uranker K; Dezzutti CS; Moncla BJ; Hillier SL
    Am J Obstet Gynecol; 2015 Aug; 213(2):204.e1-6. PubMed ID: 25818668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense.
    Cole AM; Cole AL
    Am J Reprod Immunol; 2008 Jan; 59(1):27-34. PubMed ID: 18154593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innate molecular and anatomic mucosal barriers against HIV infection in the genital tract of HIV‐exposed seronegative individuals.
    Broliden K
    J Infect Dis; 2010 Nov; 202 Suppl 3():S351-5. PubMed ID: 20887223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cultivated vaginal microbiomes alter HIV-1 infection and antiretroviral efficacy in colonized epithelial multilayer cultures.
    Pyles RB; Vincent KL; Baum MM; Elsom B; Miller AL; Maxwell C; Eaves-Pyles TD; Li G; Popov VL; Nusbaum RJ; Ferguson MR
    PLoS One; 2014; 9(3):e93419. PubMed ID: 24676219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The vaginal microbiome amplifies sex hormone-associated cyclic changes in cervicovaginal inflammation and epithelial barrier disruption.
    Bradley F; Birse K; Hasselrot K; Noël-Romas L; Introini A; Wefer H; Seifert M; Engstrand L; Tjernlund A; Broliden K; Burgener AD
    Am J Reprod Immunol; 2018 Jul; 80(1):e12863. PubMed ID: 29709092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology.
    Shannon B; Gajer P; Yi TJ; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Kaul R
    J Infect Dis; 2017 May; 215(9):1366-1375. PubMed ID: 28201724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The vaginal microbiome and HIV transmission dynamics.
    Cherenack EM; Broedlow CA; Klatt NR
    Curr Opin HIV AIDS; 2024 Sep; 19(5):234-240. PubMed ID: 38935063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.
    Cole AM; Cole AL
    Viruses; 2017 May; 9(5):. PubMed ID: 28505117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV's vagina travelogue.
    Boggiano C; Littman DR
    Immunity; 2007 Feb; 26(2):145-7. PubMed ID: 17307703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
    Zalenskaya IA; Chandra N; Yousefieh N; Fang X; Adedipe OE; Jackson SS; Anderson SM; Mauck CK; Schwartz JL; Thurman AR; Doncel GF
    J Clin Invest; 2018 Oct; 128(10):4622-4638. PubMed ID: 30222141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiome in normal and pathological pregnancies: A literature overview.
    Taddei CR; Cortez RV; Mattar R; Torloni MR; Daher S
    Am J Reprod Immunol; 2018 Aug; 80(2):e12993. PubMed ID: 29873429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis.
    Sewankambo N; Gray RH; Wawer MJ; Paxton L; McNaim D; Wabwire-Mangen F; Serwadda D; Li C; Kiwanuka N; Hillier SL; Rabe L; Gaydos CA; Quinn TC; Konde-Lule J
    Lancet; 1997 Aug; 350(9077):546-50. PubMed ID: 9284776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal Dendritic Cell Subsets Control HIV-1's Viral Fitness.
    Nijmeijer BM; Langedijk CJM; Geijtenbeek TBH
    Annu Rev Virol; 2020 Sep; 7(1):385-402. PubMed ID: 32991263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.